[1] Ott J, Stevens G, Groeger J, et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 2012,30:2212-2219.
[2] El-Serag HB. Hepatocellular carcinoma. N Engl J Med, 2011,365:1118-1127.
[3] Webster GJ RS, Brown D, Ogg GS, et al. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004, 78:5707-5719.
[4] Rosser EC, Manri C.Regulatory B Cells:Origin, phenotype, and function.Immunity, 2015,42:607-612.
[5] Mauri C,Bosma A.Immune regulatory function of B cells.Annu Rev Immunol, 2012,30:221-241.
[6] Yang M, Rui K, Wang S, et al.Regulatory B cells in autoimmune diseases.Cell Mol Immunol,2013,10:122-132.
[7] Fillatreau S.Cytokine-producing B cells as regulators of pathogenic and protective immune responses.Ann Rheum Dis,2013,72:ii8.
[8] Yanaba K, Bouaziz JD, Haas KM, et al.A regulatory B cell subset with a unique CD1dhi CD5+ phenotype controls T cell-dependent inflammatory responses.Immunity, 2008,28:639-650.
[9] Simma N,Bose T,Kahlfuss S,et al.NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.Cell Commun Signal,2014,12:75.
[10] Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious disease. Nature, 2014, 507:366-370.
[11] Mauri C, Menon M.The expanding family of regulatory B cells.Int Immunol, 2015,27:479.
[12] Lindner S, Dahlke K, Sontheimer K, et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res, 2013, 73:2468-2479.
[13] Kaku H, Cheng KF, Al-Abed Y, et al. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. J Immunol, 2014, 507:366-370.
[14] Lundy SK, Boros DL. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4(IL-4) and IL-10. Infection Immun, 2002, 70:812-819.
[15] Bankoti R, Gupta K, Levchenko A, et al. Marginal zone B cells regulate antigen-specific T cell responses during infection. J Immunol, 2012,188:3961-3971.
[16] Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol,2010,22:761-767.
[17] Boni C FP, Valdatta C, Amadei B, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007, 81:4215-4225.
[18] Das A EG, Pallant C, Lopes AR, et al. IL-10 producing regulatory B cells in the pathogenesis of chronic HBV infection. J Immunol 2012, 189:3925-3935.
[19] Gong YP, Zhao C, Zhao P, et al. Role of IL-10-producing regulatory B cells in chronic hepatitis B virus infection. Dig Dis Sci 2015, 60:1308-1314.
[20] Liu Y, Cheng LS, Wang SQ,et al. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection. Clin Sci, 2016, 130: 907-919.
[21] 刘亚允,余娇,杨阳,等.慢性乙型肝炎患者外周血分泌白细胞介素-35的B细胞和白细胞介素-35表达水平及其意义.中华传染病杂志,2017,9:528-532. |
